ICU Medical Supply Risk: 48.17% Single-Source Dependency
A supplier due diligence review of ICU Medical, Inc's exposure to ICU Medical Costa Rica Ltd reveals a concentration level that is below a catastrophic point of failure but far too high to ignore. The trial engagement and a low loyalty score of 0.38 overwhelmingly point to a transactional relationship, not a strategic partnership.
Supplier Concentration: 48.17% Is an Early Warning Signal
How to Interpret the 48.17% Dependency Ratio
ICU Medical, Inc sources 48.17% of the relevant supply volume or value from a single vendor: ICU Medical Costa Rica Ltd. This is not a single point of failure in the strictest sense — that red-line threshold is typically 80% or higher. But 48.17% is dangerously close to a level at which a sudden disruption at that supplier would trigger immediate production gaps, premium freight charges, and significant revenue loss.
| Metric | Value |
|---|---|
| Supplier Dependency | 48.17% |
| Engagement Type | Trial |
| Loyalty Score | 0.38 / 1.00 |
| Relationship Classification | Transactional |
Why a Percentage Below 80% Still Deserves Attention
The concentration risk is amplified by the relationship's trial status. A supplier holding nearly half of the relevant volume without a formal, long-term commitment has every incentive to prioritize its own goals. The buyer cannot assume supply continuity, fixed pricing, or shared risk mitigation. In practice, ICU Medical, Inc is operating with a fragile dependency that could be weaponized during contract negotiations or abandoned entirely after a short notice period.
Relationship Quality: Trial Status and Low Loyalty Spell Transactional Risk
Trial Status Means the Relationship Is Unproven
Marking the cooperation as trial indicates that ICU Medical, Inc has not formally committed to this supplier beyond an assessment stage. Trial relationships often lack binding volume agreements, service-level penalties, and governance structures. For a supplier that controls 48.17% of the buyer's relevant supply stream, that lack of contractual hardening is a serious governance gap.
Loyalty Score of 0.38 Signals Weak Trust and Low Alignment
On a 0-to-1 scale, a loyalty score of 0.38 is low. It suggests limited trust, minimal joint investment, and a transactional posture from both parties. The supplier is unlikely to go out of its way to support the buyer during a crisis, and the buyer lacks the influence to demand preferential treatment. This score does not support a strategic partnership classification.
Combined Effect: A Transactional Relationship With Outsized Power
When high share of wallet meets low loyalty and trial status, the relationship is best described as transactional. In a transactional relationship, the supplier will make decisions based primarily on its own commercial benefit. That leaves ICU Medical, Inc exposed to price renegotiation, late deliveries, and limited cooperation during disruptions.
Operational Risk Scenarios for ICU Medical, Inc
Disruption at ICU Medical Costa Rica Ltd
If the Costa Rican supplier experiences a shutdown — from labor action, regulatory sanctions, raw material shortages, or logistics failures — ICU Medical, Inc would lose nearly half of the affected supply stream. Alternative vendors are unlikely to absorb that volume quickly, which means delayed shipments to downstream customers and potential contractual penalties for the medical device maker.
Pricing Power and Negotiation Leverage
A supplier that knows it carries 48.17% dependency can confidently push for higher prices, tighter payment terms, or relaxed quality commitments. ICU Medical's bargaining position is weak because walking away from the relationship would cause immediate and severe supply disruption. The supplier effectively controls the buyer's operating stability.
Limited Visibility Into Supplier Risk
Trial relationships typically come with less data sharing, fewer joint risk reviews, and weaker reporting mechanisms. ICU Medical, Inc likely has limited insight into the Costa Rica supplier's own upstream dependencies, financial health, or factory capacity utilization. This lack of transparency makes it harder to anticipate failures and respond before they escalate.
Recommended Actions to Contain This Supplier Risk
Immediate: Build a Contingency Sourcing Playbook
- Qualify at least one alternative supplier capable of covering at least 20–25% of the volume currently placed with ICU Medical Costa Rica Ltd.
- Sign pre-approved backup supply agreements so that capacity can be activated quickly if needed.
- Conduct an urgent due diligence audit of the Costa Rica supplier's production lines, financial statements, and compliance record.
Medium-Term: Reduce Single-Supplier Dependency Below 30%
Over the next 12 to 18 months, ICU Medical, Inc should push the dependency ratio below 30%. That requires either converting the trial relationship into a formal multi-year contract with clear performance penalties, or aggressively moving volume to qualified alternative suppliers. Diversification costs are far lower than the revenue damage caused by an unplanned shutdown.
Governance: Institute a Supplier Risk Scorecard
Establish a quarterly review covering on-time delivery, defect rates, responsiveness, financial stability, and the supplier's own upstream risks. Monitor the loyalty score for sustained improvement. If it remains below 0.5 for two consecutive quarters, treat the supplier as a purely transactional source and adjust safety stock and dual-sourcing strategies accordingly.
This supplier risk brief was prepared by the TradeMagellan supply chain intelligence team based on TradeMagellan's proprietary risk-composite model. The data represents a point-in-time observation and should be used to guide, not replace, the company's internal due diligence process.
